Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Terminated 2Recruiting 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 2

Conditions

Recurrence 1Glioblastoma 1Brain Neoplasms 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Perfusion Magnetic Resonance Imaging × Clear all
NCT02613988 2024-05-14

Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas

Asan Medical Center

Phase NA Recruiting
100 enrolled
CNS

Glioblastoma

NCT05868928 2024-05-14

Imaging Features for the Risks for Recurrence After Stereotactic Radiosurgery in Brain Metastasis

Asan Medical Center

Recruiting
132 enrolled
CNS

Brain Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡